BRPI0909021A2 - uso de um polipeptídeo, polipeptídeo, e, método de tratamento de meningite - Google Patents

uso de um polipeptídeo, polipeptídeo, e, método de tratamento de meningite

Info

Publication number
BRPI0909021A2
BRPI0909021A2 BRPI0909021A BRPI0909021A BRPI0909021A2 BR PI0909021 A2 BRPI0909021 A2 BR PI0909021A2 BR PI0909021 A BRPI0909021 A BR PI0909021A BR PI0909021 A BRPI0909021 A BR PI0909021A BR PI0909021 A2 BRPI0909021 A2 BR PI0909021A2
Authority
BR
Brazil
Prior art keywords
polypeptide
treating meningitis
meningitis
treating
Prior art date
Application number
BRPI0909021A
Other languages
English (en)
Inventor
Dorthe Sandvang
Hans-Henrik Kristensen Hoegenhaug
Original Assignee
Novozymes Adenium Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909021(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novozymes Adenium Biotech As filed Critical Novozymes Adenium Biotech As
Publication of BRPI0909021A2 publication Critical patent/BRPI0909021A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0909021A 2008-04-04 2009-03-30 uso de um polipeptídeo, polipeptídeo, e, método de tratamento de meningite BRPI0909021A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154103 2008-04-04
PCT/EP2009/053726 WO2009121828A1 (en) 2008-04-04 2009-03-30 Use of defensins against meningitis

Publications (1)

Publication Number Publication Date
BRPI0909021A2 true BRPI0909021A2 (pt) 2015-09-22

Family

ID=40875112

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909021A BRPI0909021A2 (pt) 2008-04-04 2009-03-30 uso de um polipeptídeo, polipeptídeo, e, método de tratamento de meningite

Country Status (18)

Country Link
US (1) US20090253629A1 (pt)
EP (1) EP2278991A1 (pt)
JP (1) JP2011516450A (pt)
KR (1) KR20100134025A (pt)
CN (1) CN102036678A (pt)
AP (1) AP2010005403A0 (pt)
AR (1) AR071177A1 (pt)
AU (1) AU2009231463A1 (pt)
BR (1) BRPI0909021A2 (pt)
CA (1) CA2720380A1 (pt)
CL (1) CL2009000811A1 (pt)
EA (1) EA201071163A1 (pt)
IL (1) IL208189A0 (pt)
MX (1) MX2010010795A (pt)
PE (1) PE20091781A1 (pt)
TW (1) TW200942254A (pt)
WO (1) WO2009121828A1 (pt)
ZA (1) ZA201006645B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR073917A1 (es) * 2008-10-23 2010-12-09 Novozymes Adenium Biotech As Sinergismo antibiotico
TW201125577A (en) * 2009-12-02 2011-08-01 Novozymes As Use of defensins for treatment of infective endocarditis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US20040265337A1 (en) * 2002-08-21 2004-12-30 Zsebo Krisztina M. Method of generating an immune response and compositions used for same
MX2007005520A (es) * 2004-11-12 2007-07-09 Novozymes As Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican los mismos.
EP1850861A1 (en) * 2005-02-08 2007-11-07 Novozymes A/S Systemic treatment of infections with defensins
BRPI0609801B1 (pt) * 2005-06-06 2018-05-29 Novozymes Adenium Biotech A/S Polipeptídeo, polinucleotídeo, construção de ácido nucleico, vetor de expressão recombinante,microrganismo recombinante, método para produção do polipeptídeo, composição antimibrobiana, método in vitro para matar ou inibir o crescimento 5 de células microbianas, e, uso de um polipeptídeo antimicrobiano

Also Published As

Publication number Publication date
MX2010010795A (es) 2011-01-12
AR071177A1 (es) 2010-06-02
CA2720380A1 (en) 2009-10-08
JP2011516450A (ja) 2011-05-26
CL2009000811A1 (es) 2010-05-07
AP2010005403A0 (en) 2010-10-31
TW200942254A (en) 2009-10-16
IL208189A0 (en) 2010-12-30
PE20091781A1 (es) 2009-12-03
US20090253629A1 (en) 2009-10-08
ZA201006645B (en) 2011-06-29
EA201071163A1 (ru) 2011-04-29
WO2009121828A1 (en) 2009-10-08
CN102036678A (zh) 2011-04-27
KR20100134025A (ko) 2010-12-22
EP2278991A1 (en) 2011-02-02
AU2009231463A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
BRPI1010798A2 (pt) fechamento, aparelho de retenção, e método de uso do mesmo
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0913227A2 (pt) método, e objeto
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
PL2358756T3 (pl) Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
BRPI0919575A2 (pt) método, e, composição
BRPI0920145A2 (pt) compostos de tioamida, método de produção e método de uso dos mesmos
EP2236573A4 (en) ANTI-FREEZING COATING AND METHOD OF APPLICATION
BRPI0823277A2 (pt) Composição, e , método
BR112012031232A2 (pt) método, dispositivo e uso
BR112013013523A2 (pt) centralizador, método, e, uso de um centralizador
DE602008005239D1 (de) Navigationsvorrichtung, Navigationsverfahren und Navigationsprogramm
BRPI1006996A2 (pt) composição, método e uso
BRPI0915134A2 (pt) composto, e, uso de um composto
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI0908100A2 (pt) produto combinação, uso de um composto, e, método de tratar câncer
BRPI0919216A2 (pt) poliuretano, e, uso de um poliuretano
BRPI0809573A8 (pt) composição, e, método
BRPI1013112A2 (pt) método de cimentação, e, composição de cimento
BRPI0912799A2 (pt) fluxímetro, e, método
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0913188A2 (pt) moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
BRPI0816835A2 (pt) dispositivo de pulverização e método de uso do mesmo
BRPI0814167A2 (pt) Composição, e, método

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.